Paper825477
Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease.
Pross HF and 1 other. Int J Cancer, 1976. Cited by 263 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease. Papers, record 825477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/825477
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunity, Cellular | Major topic |
| Leukemia, Lymphoid | Major topic |
| Lymphocytes | Major topic |
| Mast-Cell Sarcoma | Major topic |
| Adult | |
| Aged | |
| Animals | |
| B-Lymphocytes | |
| Cell Line | |
| Complement System Proteins | |
| Cytotoxicity Tests, Immunologic | |
| Humans | |
| Hypersensitivity, Delayed | |
| Immunoglobulin Fc Fragments | |
| Leukemia, Myeloid | |
| Middle Aged | |
| Neoplasm Metastasis | |
| Sarcoma, Experimental | |
| T-Lymphocytes |
Source PubMed
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 263 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,882,209 | Natural killer cells in cancer immunotherapy. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/38882209 | PubMed |
| 34,445,750 | Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445750 | PubMed |
| 34,017,344 | Epigenetic Regulation of NK Cell-Mediated Antitumor Immunity. | Front Immunol | 2021 | https://conductscience.org/library/papers/34017344 | PubMed |
| 32,733,432 | NK Cell Development in Times of Innate Lymphoid Cell Diversity. | Front Immunol | 2020 | https://conductscience.org/library/papers/32733432 | PubMed |
| 27,262,776 | Low intensity vibration mitigates tumor progression and protects bone quantity and quality in a murine model of myeloma. | Bone | 2016 | https://conductscience.org/library/papers/27262776 | PubMed |
| 27,007,115 | Ionomycin Treatment Renders NK Cells Hyporesponsive. | PLoS One | 2016 | https://conductscience.org/library/papers/27007115 | PubMed |
| 24,941,370 | Natural killer activity: early days, advances, and seminal observations. | Crit Rev Oncog | 2014 | https://conductscience.org/library/papers/24941370 | PubMed |
| 18,368,320 | Preventive effect of a traditional herbal medicine, Hochu-ekki-to, on immunosuppression induced by surgical stress. | Surg Today | 2008 | https://conductscience.org/library/papers/18368320 | PubMed |
| 12,732,987 | Change in mitochondrial membrane potential in peripheral blood lymphocytes, especially in natural killer cells, is a possible marker for surgical stress on the immune system. | World J Surg | 2003 | https://conductscience.org/library/papers/12732987 | PubMed |
| 8,422,669 | Prognostic value of non-MHC-restricted killer cell activity in lung cancer. | Cancer Immunol Immunother | 1993 | https://conductscience.org/library/papers/8422669 | PubMed |
| 8,125,271 | Genetics of life span in mice. | Genetica | 1993 | https://conductscience.org/library/papers/8125271 | PubMed |
| 7,690,772 | Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum. | J Clin Invest | 1993 | https://conductscience.org/library/papers/7690772 | PubMed |
| 7,389,219 | Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus. | Clin Exp Immunol | 1980 | https://conductscience.org/library/papers/7389219 | PubMed |
| 7,334,070 | Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. | J Clin Immunol | 1981 | https://conductscience.org/library/papers/7334070 | PubMed |
| 7,138,766 | Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7138766 | PubMed |
| 7,114,924 | Natural killer cell activity in untreated systemic lupus erythematosus. | Ann Rheum Dis | 1982 | https://conductscience.org/library/papers/7114924 | PubMed |
| 7,061,569 | Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors. | J Cancer Res Clin Oncol | 1982 | https://conductscience.org/library/papers/7061569 | PubMed |
| 7,002,768 | The effect of BCG stimulation on natural cytotoxicity in the rat. | Immunology | 1980 | https://conductscience.org/library/papers/7002768 | PubMed |
| 6,978,346 | Studies of human natural killer cells. III. Neutropenia associated with unusual characteristics of antibody-dependent and natural killer cell-mediated cytotoxicity. | J Clin Immunol | 1982 | https://conductscience.org/library/papers/6978346 | PubMed |
| 6,976,792 | Specific and non-specific lymphocyte cytotoxicity in colon carcinoma. | Br J Cancer | 1981 | https://conductscience.org/library/papers/6976792 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/825477
GET https://conductscience.org/api/papers/v1/825477/cited_by?page=2